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African tick-bite fever (ATBF) is a rickettsiosis caused
by Rickettsia africae. We describe histologic features and
immunodetection of R. africae in cutaneous inoculation
eschars from 8 patients with ATBF, which was diagnosed
by culture or association of positive PCR detection and
positive serologic results. We used quantitative image
analysis to compare the pattern of inflammation of these
eschars with those from Mediterranean spotted fever. We
evaluated the diagnostic value of immunohistochemical
techniques by using a monoclonal antibody to R. africae.
ATBF eschars were histologically characterized by inflam-
mation of vessels composed mainly of significantly more
polymorphonuclear leukocytes than are found in cases of
Mediterranean spotted fever (p<0.05). Small amounts R.
africae antigens were demonstrated by immunohistochem-
ical examination in 6 of 8 patients with ATBF. Neutrophils in
ATBF are a notable component of the host reaction, per-
haps because ATBF is a milder disease than the other rick-
ettsioses. Immunohistochemical detection of rickettsial
antigens may be useful in diagnosing ATBF.
A
frican tick-bite fever (ATBF), a recently rediscovered
rickettsiosis of the spotted fever group, is caused by
Rickettsia africae, an obligate intracellular, gram-negative,
rod-shaped bacterium, transmitted by cattle ticks of the
Amblyomma genus (1–5). ATBF is highly prevalent in
Africa and often affects visitors to this region (1,6–8). In
patients, ATBF manifests as an acute, febrile, and influen-
zalike illness, frequently accompanied by severe headache,
prominent neck muscle myalgia, inoculation eschars
(which appear as black crusts surrounded by a red halo at
the site of the tick bite), and regional lymphadenitis (5). As
many as 50% of patients have multiple eschars (1).
Inoculation eschars occur at the sites of tick bites and
consist of a focus of epidermal and dermal necrosis ≈1 cm
in diameter; they represent the portal of entry of the infec-
tious agent into the host and the first site of challenge
between the infected human host and the bacterium.
Eschars have been reported and their pathologic features
have been described in other spotted fever rickettsioses
such as Mediterranean spotted fever, North Asian tick
typhus, or Queensland tick typhus (9–11). Despite several
clinical descriptions of ATBF, the pathologic features of
the inoculation eschar have not yet been described. To
determine the pathologic characteristics associated with R.
africae infection at the cutaneous level, we analyzed skin
biopsy specimens of patients with confirmed ATBF and
compared the results with those from patients with
Mediterranean spotted fever, the rickettsiosis caused by R.
conorii, with respect to the pattern of inflammatory reac-
tion. Moreover, we performed immunohistologic testing
for localization of the bacteria in skin biopsy specimens.
The specific detection of R. africae may be useful when
ATBF is suspected, especially in differentiating this rick-
ettsiosis from other spotted fever group rickettsioses.
Patients, Materials, and Methods
Case Definition
Patients referred to our laboratory from 1999 to 2004
were classified as definite cases of R. africae infection if
this rickettsia was isolated from clinical specimens or a
positive PCR detection was associated with a positive
serologic test result. Of these, we selected those for whom
inoculation eschar biopsy specimens had been formalin
fixed and paraffin embedded for histopathologic analysis.
Serology, PCR, and Culture
Immunofluorescence assays, the reference diagnostic
method, were carried out by using both R. conorii strain
Seven (Malish, ATCC VR-613T) and R. africae strain
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*Université de la Méditerranée, Marseille, France ESF-5 as antigens (6). Titers of 64 for IgG and 32 for IgM
in patient serum specimens were considered evidence of
recent infection by a Rickettsia sp. (12–14). Western blot-
ting and cross-absorption procedures were performed
(15–17). The microorganism was isolated in the manner
previously reported (6). DNA was extracted from material
frozen at –80°C. DNA was extracted from ground eschar
biopsy specimens by using the QIAmp Tissue kit (Qiagen
GmbH, Hilden, Germany), according to the manufactur-
er’s recommendations. These DNA extracts were used as
templates in a PCR assay incorporating the ompA primers
190-70 and 190-701 (18). For negative controls, we used
sterile water processed as described and DNA extracted
from a heart valve from a patient with degenerative valvu-
lopathy. For positive controls, we used DNAfrom R. mon-
tanensis strain M/5-6. Testing was performed in a blinded
manner. All positive PCR products were sequenced in both
directions (19). When regular PCR did not detect rickettsi-
ae in skin biopsy specimens, we used a nested PCR incor-
porating the ompA-amplifying primer sets AF1F–AF1R
and then AF2F–AF2R for the nested amplification (1).
Every 6 specimens, we incorporated the above-described
negative controls. To avoid contamination, we did not
include any positive control in the assay. Positive nested
PCR products were identified by sequencing with the
AF2F–AF2R primer pair.
Histologic Analysis and Immunohistochemical
Detection of R. africae
Formalin-fixed, paraffin-embedded skin biopsy speci-
mens of the inoculation eschars were cut to 3 µm in thick-
ness and stained with hematoxylin-eosin-saffron by
routine staining methods. Serial sections of each tissue
specimen were also obtained for special staining or
immunohistochemical investigations. Immunohisto-
chemical analysis was performed on paraffin-embedded
skin biopsy sections by use of the monoclonal mouse anti-
body AF8-F3 produced against R. africae (20). The speci-
ficity of this antibody has been tested on a variety of
rickettsiae, and cross-reactivity was found only with R.
parkeri and R. sibirica (20). The immunohistologic proce-
dure, in which an immunoperoxidase kit was used, has
been described elsewhere (21). Briefly, after deparaffiniza-
tion, each tissue section was incubated with the monoclon-
al anti–R. africae antibody diluted 1:1000 in phosphate-
buffered saline. After the sections were incubated with the
primary antibody, immunodetection was performed with
biotinylated immunoglobulins, followed by peroxidase-
labeled streptavidin (HistoStain plus kit, Zymed,
Montrouge, France) with amino-ethyl-carbazole as sub-
strate. The slides were counterstained with Mayer hema-
toxylin for 10 min. For each case, 3 level tissue sections
were systematically evaluated by immunohistochemical
analysis, and a negative control was created by using an
irrelevant monoclonal mouse antibody. Moreover, to test
the specificity of our monoclonal antibody, skin biopsy
specimens from patients with Mediterranean spotted fever
(15 cases), acute eczematous dermatitis (2 cases), psoriasis
(2 cases), and lichen planus (1 case) served as negative
controls.
Quantitative Image and Statistical Analyses
To characterize the immune response in inoculation
eschars during ATBF and Mediterranean spotted fever,
paraffin sections were stained with the polymorphonuclear
leukocyte marker CD15 (Immunotech, Marseille, France),
the macrophage marker CD68 (Dako, Trappes, France),
the T-lymphocyte marker CD3 (Dako), the B-lymphocyte
marker CD20 (L26, Dako), and the endothelial cell mark-
er Factor VIII–related antigen (Dako) by using the peroxi-
dase-based method described above. The antibodies
anti-CD15 and anti-CD3 were ready to use, whereas the
antibodies anti-CD68, anti-CD20, and anti-Factor VIII–
related antigen were used at a working dilution of 1:1000.
The evaluation of the proportion of polymorphonuclear
leukocytes, macrophages, T lymphocytes, and B lympho-
cytes, as well the relative proportion of neovascularization
in skin tissue specimens, was determined by quantitative
image analysis (22). In brief, histologic images were digi-
tized and transferred to a computer system. Using the
image analyzer SAMBA 2005 (SAMBA Technologies),
which is a specific interactive program that provides visu-
al control of analysis, we analyzed the CD15-positive,
CD68-positive, CD3-positive, CD20-positive, and Factor
VIII–positive surfaces in tissue sections to determine the
percentages of the total surface area covered by neu-
trophils, macrophages, T and B lymphocytes, and endothe-
lial cells, respectively. For each set of observations, the
surfaces of 10 randomly chosen areas were studied at a
magnification  ×100, and the surface areas of each
immunohistologic parameter were measured. The average
areas were calculated by comparison with the area of the
whole tissue sample. The Mann-Whitney U test was used
for the statistical comparisons of values that were obtained
for each immunohistologic parameter for skin biopsy
specimens from patients with ATBF and patients with
Mediterranean spotted fever; p<0.05 was considered
significant.
Value of Immunohistochemical Techniques 
The sensitivity, specificity, and positive and negative
predictive values of immunohistochemical techniques for
the diagnosis of ATBF were calculated. The sensitivity of
immunohistochemical analysis was compared to that of
culture, regular PCR, nested PCR, and serologic testing by
using the Fisher exact test.
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Skin biopsy specimens from 8 patients with ATBF,
from 1999 to 2004, obtained from black crusts correspon-
ding to inoculation eschars, were positive for R. africae by
culture (4 patients) or PCR and serologic tests (4 patients).
The age of the eschars at the time of biopsy varied from 5
to 10 days. The epidemiologic and clinical features of the
cases in the 8 patients with ATBF are summarized in
Table 1. The mean age of patients was 46.87 years (stan-
dard deviation 13.17 years, range 27–63 years); 4 were
men and 4 were women. A history of tick bite was report-
ed by 3 (37.5%) of 8 patients. Clinical features included
fever in 6 (75%) of 8 patients, a vesicular cutaneous rash
in 5 (62.5%) of 8 patients, regional lymphadenopathies in
3 (42.85%) of 7 patients, and headache and myalgia in 5
(71.42%) of 7 patients. The inoculation eschar was single
in 3 (37.5%) of 8 patients and multiple in 5 (62.5%) of 8
patients. Erythema and swelling surrounded the eschar in 7
(87.5%) of 8 patients. Details of the results of laboratory
tests, culture, serologic tests, PCR, and immunohistochem-
ical tests are found in Table 2.
Histologic and Immunohistochemical Analyses
Eschars of ATBF cases were histologically dominated
by vascular injury and perivasculitis, which were detected
in all skin biopsy specimens examined. The host response
to the vascular injury was manifested as intramural and
perivascular infiltration by polymorphonuclear leukocytes,
small lymphocytes, and macrophages (Figure 1). Vascular
damages were endothelial swelling and vascular fibrinoid
necrosis (Figure 2). Mural and occlusive fibrin thrombi
were observed in a few blood vessels. Vascular injuries
were associated with cutaneous necrosis (Figure 2).
Moderate-to-severe cutaneous necrosis was present in 7 of
8 cutaneous biopsy specimens. When cutaneous necrosis
was found, it was associated with vascular thrombosis. No
hemorrhages were noted. Quantitative immunohistochem-
ical analysis showed that the immune response in skin
biopsy specimens from patients with ATBF more predom-
inantly involved polymorphonuclear leukocytes than did
specimens from patients with Mediterranean spotted fever
(p<0.01, Figures 3 and 4). In contrast, the inflammatory
infiltrates in patients with Mediterranean spotted fever
were mainly characterized by macrophages (p = 0.04,
Figure 4) and T and B lymphocytes. The relative amounts
of vessel formation were similar in the 2 diseases.
Six of 8 eschar biopsy specimens contained R. africae
detected by immunohistochemical analysis (Table 2).
Rickettsial antigen was observed in the endothelium and
inflammatory cells organized in and around blood vessels
(Figure 5). None of the control skin biopsy samples,
including the R. conorii–infected cutaneous specimens,
showed immunoreactivity with the monoclonal mouse
antibody AF8-F3. Finally, no statistical correlations were
found between the age of the cutaneous lesions and the
amount and type of inflammatory cell infiltrate as well as
the amount of rickettsial antigen found in the lesion.
The sensitivity, specificity, and positive and negative
predictive values of immunohistochemistry were 75%,
100%, 100%, and 91%, respectively. The sensitivity of
immunohistochemical tests was not significantly different
from that of culture (6/8 vs 4/8, p = 0.6), regular PCR (6/8
vs 6/8, p = 1), nested PCR (6/8 vs 8/8, p = 0.5), and serol-
ogy (6/8 vs 4/8, p = 0.6) (1,12,28).
Discussion
In some rickettsioses, the inoculation eschar is the site
of an intense rickettsial multiplication and thus is the pre-
ferred biopsy specimen for studying the pathologic fea-
tures of Rickettsia-induced infection and for detecting the
bacteria by immunohistologic tests as well as for carrying
out isolation procedures or genomic detection. As demon-
strated before for many rickettsioses, the cutaneous dam-
ages at the inoculation site were histologically dominated
by vasculitis and necrotic features (11). Rickettsial inva-
sion of endothelial cells probably represents the first step
of infection (7). Subsequent damage to the endothelium is
followed by endothelial-cell activation and perivascular
infiltration of lymphocytes, macrophages, and polymor-
phonuclear leukocytes, resulting in inflammatory vasculi-
tis of dermal vessels, the histopathologic hallmark of
rickettsial disease, and possibly thrombosis (23). However,
in contrast with the other rickettsial diseases that are
characterized by perivascular infiltration of T cells and
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trophils (10,24–26), the cutaneous damage of ATBF show
vasculitis with polymorphonuclear leukocyte–rich inflam-
mation. The predominance of neutrophils in inflammatory
infiltrates may explain the importance of the local inflam-
mation clinically observed at the site of inoculation,
accompanied by the regional lymphadenitis.
By using immunohistochemical techniques, we demon-
strated  R. africae in cutaneous biopsy specimens from
patients with ATBF. In accord with its obligate intracellu-
lar location, no extracellular organisms were observed in
cutaneous biopsy specimens. Few bacterial antigens were
found in vascular and perivascular locations within the
cytoplasm of endothelial and inflammatory cells. In spite
of the small amount of antigens detected, the inflammato-
ry and necrotic cutaneous damage was histologically
extensive. Our data indicate that R. africae replicates poor-
ly in human tissues, likely because of its mild pathogenic-
ity and the strong innate immune response. The local
destruction of bacteria by the inflammatory reaction may
explain the benign outcome of the disease.
In our study, immunohistochemical techniques had a
sensitivity of 75%, a specificity of 100%, and a positive
predictive value of 100%. Serologic tests, the most widely
used diagnostic method for rickettsioses, had a sensitivity
of 56% in early samples (12). Although our data suggested
that immunohistochemical analysis might be more sensi-
tive than serology in early samples, statistical analysis
showed no significant difference between the 2 techniques.
Regarding diagnostic methods applicable to skin biopsy
specimens, immunochemical techniques were also more
sensitive than culture (41%), which is restricted to special-
ized laboratories equipped with biohazard facilities; such
techniques were also more sensitive than regular PCR
(47%) (27). Moreover, the techniques exhibited a sensitiv-
ity similar to that of nested PCR (73.5%), previously found
to be the most efficient diagnostic technique for spotted
fever rickettsioses (27).
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Figure 1. Fibrinoid necrosis of a vessel in the dermis (arrow) with
perivascular inflammatory infiltrates mainly composed of polymor-
phonuclear leukocytes (hematoxylin-eosin-saffron; original magni-
fication ×250).
Figure 2. Coagulative necrosis (*) of the dermis surrounding
necrotic vessels (arrow) (hematoxylin-eosin-saffron; original mag-
nification ×250).
Figure 3. Inoculation eschar from a patient with African tick-bite
fever showing numerous dermal inflammatory infiltrates mainly
composed of polymorphonuclear leukocytes (immunoperoxidase
staining with an anti-CD15 antibody; original magnification ×100).As Mediterranean spotted fever caused by R. conorii is
endemic in the same regions of Africa as tick-bite fever, dif-
ferentiation of the 2 syndromes by characterization of their
etiologic agents may be useful for diagnostic and epidemi-
ologic studies (4,28,29). The polymorphonuclear leuko-
cyte–rich vasculitis, which dominates the histologic
features of the inoculation eschar during ATBF, could sug-
gest the diagnosis of this rickettsiosis but is not specific.
The usual method for the diagnosis of rickettsioses is sero-
logic testing. However, serologic cross-reactions are com-
mon among the rickettsiae in the spotted fever group,
particularly between R. africae and R. conorii infections
(6). Monoclonal antibodies had been developed to R.
africae for use in assays to distinguish between R. conorii
and R. africae in culture and skin biopsy samples (20). In
this study, we used a monoclonal antibody produced in our
laboratory to distinguish ATBF from Mediterranean spotted
fever at the histologic level by immunohistologic methods.
We presented the pathologic description of the first series of
inoculation eschars from skin biopsy specimens of patients
with ATBF. We showed that cutaneous damage is dominat-
ed by vasculitis, thrombosis, cutaneous necrosis, and a
polymorphonuclear leukocyte–rich inflammatory reaction.
Immunohistochemical detection of rickettsial antigens may
be useful in diagnosing ATBF. Pathologists should now
consider ATBF, a recently rediscovered rickettsiosis, during
histologic analysis of inoculation eschars, especially in
patients with a recent stay in sub-Saharan Africa.
Dr Lepidi is an associate professor of pathology at the
Université de la Méditerranée, Marseille. His research interests
include the pathology of infectious diseases, especially bacteria
with intracellular development and rickettsioses.
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